Exploiting metabolic cell death for cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Metabolic Pathways

Background:

• Resistance to cell death is a key characteristic of cancer, hindering treatment effectiveness.
• Metabolic cell death pathways, including ferroptosis, cuproptosis, and disulfidptosis, represent emerging vulnerabilities in cancer therapy.
• These distinct pathways are each initiated by specific metabolic disruptions within cancer cells.

Purpose of the Study:

• To review the molecular mechanisms and regulatory networks of ferroptosis, cuproptosis, and disulfidptosis in cancer.
• To explore the potential crosstalk between these metabolic cell death pathways.
• To discuss how ferroptosis research can inform strategies for targeting cuproptosis and disulfidptosis in cancer treatment.

Main Methods:

• Literature review of molecular mechanisms governing metabolic cell death.
• Analysis of regulatory networks controlling cancer cell death pathways.
• Examination of potential crosstalk and therapeutic implications.

Main Results:

• Detailed examination of the molecular underpinnings of ferroptosis, cuproptosis, and disulfidptosis.
• Identification of potential interactions and crosstalk between these cell death modalities.
• Highlighting the complex and often dual roles of metabolic cell death in cancer progression and treatment.

Conclusions:

• Metabolic cell death pathways present unique targets for cancer therapy.
• Leveraging insights from ferroptosis research can accelerate the development of therapies for cuproptosis and disulfidptosis.
• Developing innovative cancer treatments requires a comprehensive understanding of metabolic cell death processes.